Milan

• An Open Label, Single Arm, Phase I/II Clinical Study of Autologous CD4+ T-Cells Edited Ex-Vivo at the CD40LG Locus by CRISPR/Cas9 and IDLV-b … Pending
  2025-524635-39-00 7 X-linked immunodeficiency with hyper-IgM type 1 (HIGM1)
• Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combination for Inflammatory Bowel Disease Pending
  2025-524640-35-00 4 Ulcerative colitis (Inflammatory Bowel Disease)
• Open-label study of BBO-11818 in adult subjects with KRAS mutant cancer Pending
  2025-524690-16-00 1 Solid Tumors
• SYMBIOTIC-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Previously Untreated Parti … Pending
  2025-524717-86-00 10 LOCALLY ADVANCED OR METASTATIC GASTRIC, GASTROESOPHAGEAL JUNCTION, OR
• A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic P … Pending
  2025-525009-18-00 5 Pancreatic Ductal Adenocarcinoma
• SERENDIPITY: phase III multicentric randomized study assessing the reduction of chronic prostate inflammation with Permixon® Pending
  2025-525123-27-00 5 Benign prostatic hypertrophy
• A Phase 2, Open-Label Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the S … Pending
  2025-525124-10-00 4 Duchenne Muscular Dystrophy
• Prospective, multicenter, randomized study on combined LT4 + LT3 therapy versus LT4 in the control of TSH in patients with advanced thyroid … Pending
  2026-526113-28-00 6 Advanced thyroid carcinoma. Post-thyroidectomy hypothyroidism.
• A Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with Relapsed or Refractory Multiple Myeloma Recruiting
  2025-523815-12-00 5 2026-07-06 Relapsed or Refractory Multiple Myeloma
• A Phase II, Open-Label, Single-Arm, Multicentre Study of Carboplatin, Paclitaxel, and Tislelizumab in Biomarker-Selected Patients with Resec … Recruiting
  2024-517565-16-00 4 2026-07-01 Resectable Locally Advanced Oral Cavity Squamous Cell Carcinoma
• A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in People With Hemophilia A Recruiting
  2025-522434-32-00 5 2026-07-01 Hemophilia A Without Inhibitors
• A clinical trial of ifinatamab deruxtecan in people under age 18 who have certain types of cancer (MK-9999-01D) Recruiting
  2025-522339-32-00 9 2026-06-30 Neoplasm malignant
• ​A study to evaluate safety and explore efficacy of new lipase NHS7108 compared with pancrelipase in adult participants with exocrine pancre … Recruiting
  2025-521816-20-00 4 2026-06-29 ​​Exocrine Pancreatic Insufficiency​
• A clinical trial of MK-8690 in people with ulcerative colitis (MK-8690-002) Recruiting
  2025-523479-49-00 4 2026-06-29 Colitis ulcerative
• A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3) Recruiting
  2025-524404-29-00 4 2026-06-24 Ulcerative Colitis, Active Moderate
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active ulcerative coliti … Recruiting
  2025-521038-27-00 5 2026-06-23 Immune system diseases
• A Phase 1b/2 Study to Evaluate NB-4746 in Participants with Amyotrophic Lateral Sclerosis. Recruiting
  2025-523939-18-00 9 2026-06-23 Amyotrofic Lateral Sclerosis (ALS)
• A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003) Recruiting
  2025-524894-17-00 10 2026-06-22 Neovascular age-related macular degeneration (NVAMD)
• Perioperative Therapy with Durvalumab Plus Tremelimumab for Patients with Resectable Hepatocellular Carcinoma (HCC) - A Phase II Trial (NEOT … Recruiting
  2023-508863-59-01 4 2026-06-17 Resectable Hepatocellular Carcinoma
• A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People with Hemophilia A Recruiting
  2025-522435-33-00 5 2026-06-17 Hemophilia A
• A clinical trial of MK-1084 and durvalumab in people with non-small cell lung cancer (MK-1084-015) Recruiting
  2025-522038-29-00 5 2026-06-16 Locally advanced, unresected (unresectable or medically inoperable or
• A clinical trial of V940 with or without MK-3475A in people with non-small cell lung cancer (V940-014) Recruiting
  2025-522643-18-00 5 2026-06-16 Stage I NSCLC
• A Phase 1b/2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of IM-101 in Adult Participants with Generalized Myasthenia Gr … Recruiting
  2025-522406-20-00 9 2026-06-15 Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
• A clinical study of MK-1045 in people with non-Hodgkin lymphoma (MK-1045-008) Recruiting
  2025-523005-15-00 9 2026-06-15 Non-Hodgkin Lymphoma

Showing 169–192 of 2,391 trials